438 results
8-K
EX-99.1
SEEL
Seelos Therapeutics Inc
19 Mar 24
Other Events
4:05pm
neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement. In ALS, both the upper motor neurons
424B3
zk9l9cod8xata4ngv50t
15 Mar 24
Prospectus supplement
4:15pm
8-K
EX-4.1
9u80x
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
biuwru8 khjf
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
wvybt5s bti
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
6kebhmez5qztz6gyrxf
30 Jan 24
Prospectus supplement for primary offering
6:05am
UPLOAD
rqrbb1fuj2ge4
21 Dec 23
Letter from SEC
12:00am
8-K
EX-1.1
j85rzcmds1 t4av
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm